Epitope Mapping and Fine Specificity of Human T and B Cell Responses for Novel Candidate Blood-Stage Malaria Vaccine P27A.
Adjuvants, Immunologic
Adult
Antibodies, Protozoan
/ metabolism
Antibody Affinity
Antigens, Protozoan
/ genetics
Epitope Mapping
/ methods
Epitopes, B-Lymphocyte
/ genetics
Epitopes, T-Lymphocyte
/ genetics
Humans
Life Cycle Stages
Lymphocyte Activation
Malaria Vaccines
/ immunology
Malaria, Falciparum
/ immunology
Peptides
/ genetics
Plasmodium falciparum
Protozoan Proteins
/ genetics
Switzerland
Tanzania
Vaccination
P27A
Plasmodium falciparum
adjuvant
clinical trial
immune response
malaria
populations
vaccine
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2020
2020
Historique:
received:
03
12
2019
accepted:
21
02
2020
entrez:
27
3
2020
pubmed:
27
3
2020
medline:
16
3
2021
Statut:
epublish
Résumé
P27A is a novel synthetic malaria vaccine candidate derived from the blood stage
Identifiants
pubmed: 32210975
doi: 10.3389/fimmu.2020.00412
pmc: PMC7076177
doi:
Substances chimiques
Adjuvants, Immunologic
0
Antibodies, Protozoan
0
Antigens, Protozoan
0
Epitopes, B-Lymphocyte
0
Epitopes, T-Lymphocyte
0
Malaria Vaccines
0
Peptides
0
Protozoan Proteins
0
Tex1 protein, Plasmodium falciparum
0
Types de publication
Clinical Trial, Phase I
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
412Informations de copyright
Copyright © 2020 Geiger, Guignard, Yang, Bikorimana, Correia, Houard, Mkindi, Daubenberger, Spertini, Corradin and Audran.
Références
J Mol Recognit. 2012 Nov;25(11):616-22
pubmed: 23108621
PLoS One. 2007 Jul 25;2(7):e645
pubmed: 17653272
Chem Sci. 2016 Feb 1;7(2):842-854
pubmed: 28791117
NPJ Vaccines. 2018 Sep 4;3:34
pubmed: 30210819
J Mol Biol. 1999 Oct 22;293(2):321-31
pubmed: 10550212
Mol Biochem Parasitol. 2006 Dec;150(2):256-67
pubmed: 17010454
Nature. 2002 Oct 3;419(6906):498-511
pubmed: 12368864
Endocr Metab Immune Disord Drug Targets. 2007 Dec;7(4):259-65
pubmed: 18220946
Hum Vaccin Immunother. 2017 Sep 2;13(9):2098-2101
pubmed: 28272979
Pharm Stat. 2011 Mar-Apr;10(2):128-34
pubmed: 22328315
Adv Immunol. 2012;114:107-49
pubmed: 22449780
Infect Immun. 2009 Dec;77(12):5701-9
pubmed: 19786562
Annu Rev Microbiol. 2018 Sep 8;72:273-292
pubmed: 30200856
Malar J. 2014 Dec 19;13:510
pubmed: 25526742
Sci Transl Med. 2010 Sep 22;2(50):50rv3
pubmed: 20861510
PLoS One. 2012;7(10):e46112
pubmed: 23056243
J Exp Med. 2019 Aug 5;216(8):1857-1873
pubmed: 31175140
PLoS One. 2012;7(6):e38898
pubmed: 22768052
Proteome Sci. 2006 May 31;4:12
pubmed: 16737525
Lancet Respir Med. 2018 Apr;6(4):287-298
pubmed: 29595510
Clin Infect Dis. 2019 Jan 18;68(3):466-474
pubmed: 29945169
J Infect Dis. 2008 Jul 1;198(1):134-42
pubmed: 18471084
Front Immunol. 2018 Nov 29;9:2769
pubmed: 30555463